Skip to main content
. 2009 Dec;139(12):2301–2308. doi: 10.3945/jn.109.109900

TABLE 1.

Baseline anthropometric and biological characteristics for participants of the Boston Puerto Rican Health Study1

APOA5-1131T > C
APOA5 S19W
TT TC+CC CC CG+GG All participants
n 618 184 639 163 802
Female, n (%) 458 (74.1) 129 (70.1) 452 (70.7) 135 (82.8)* 587 (73.2)
Age, y 57.9 ± 7.2 57.5 ± 7.1 57.9 ± 7.2 57.6 ± 7.2 57.8 ± 7.2
BMI, kg/m2 32.2 ± 6.7 32.1 ± 7.0 32.0 ± 6.8 33.0 ± 6.6 32.2 ± 6.8
Waist circumference, cm 101.7 ± 15.1 101.8 ± 14.6 101.4 ± 15.0 103.2 ± 15.0 101.8 ± 15.0
Physical activity score 31.4 ± 4.5 32.0 ± 4.5 31.5 ± 4.5 31.8 ± 4.4 31.5 ± 4.5
SBP, mm Hg 136.2 ± 18.2 135.3 ± 19.7 136.1 ± 18.5 135.6 ± 19.0 136.0 ± 18.6
DBP, mm Hg 81.2 ± 10.6 80.7 ± 10.2 81.0 ± 10.5 81.5 ± 10.6 81.1 ± 10.5
Biochemistry
    Serum glucose, mmol/L 6.78 ± 2.69 6.69 ± 3.25 6.73 ± 2.88 6.87 ± 2.64 6.76 ± 2.83
    Plasma TG, mmol/L 1.80 ± 1.23 1.95 ± 1.82 1.87 ± 1.49 1.71 ± 0.90 1.84 ± 1.39
    Plasma HDL-C, mmol/L 1.16 ± 0.33 1.15 ± 0.33 1.17 ± 0.34 1.14 ± 0.29 1.16 ± 0.33
    Plasma LDL-C, mmol/L 2.80 ± 0.84 2.73 ± 0.95 2.77 ± 0.91 2.81 ± 0.89 2.78 ± 0.90
    Plasma VLDL-C, mmol/L 0.75 ± 0.38 0.79 ± 0.38 0.77 ± 0.39 0.74 ± 0.35 0.76 ± 0.38
    Plasma total cholesterol, mmol/L 4.77 ± 1.09 4.70 ± 1.13 4.77 ± 1.11 4.70 ± 1.02 4.75 ± 1.10
Energy intake, kJ/d 9039 ± 3603 8938 ± 3859 8959 ± 3640 9239 ± 3744 9016 ± 3661
Total fat, % energy 31.1 ± 5.1 30.5 ± 5.6 30.9 ± 5.3 31.1 ± 5.1 52.0 ± 7.6
Carbohydrate, % energy 51.9 ± 7.3 52.3 ± 8.5 51.9 ± 7.7 52.4 ± 7.2 17.3 ± 3.5
Protein, % energy 17.2 ± 3.4 17.5 ± 3.6 17.3 ± 3.5 17.1 ± 7.2 31.0 ± 5.2
European ancestry,2% 56.9 ± 15.2 52.3 ± 8.5 57.3 ± 15.4 56.4 ± 14.6 27.4 ± 15.7
African ancestry,2% 27.7 ± 15.7 26.5 ± 15.8 27.2 ± 15.9 28.4 ± 14.9 57.1 ± 15.3
Native American ancestry,2% 15.4 ± 6.6 15.5 ± 6.7 15.5 ± 6.7 15.1 ± 6.1 15.4 ± 6.6
Current smoker, % 23.0 22.4 22.6 23.8 22.8
Current drinker, % 40.3 37.0 40.6 35.2 39.5
Diabetes medication use, % 32.6 36.6 34.4 30.2 33.5
Hypertension medication use, % 56.3 55.7 56.5 54.9 56.2
Lipid-lowering medication use, % 41.4 38.3 40.2 42.6 40.7
MetS3
67.3
64.3
66.5
67.1
66.6
1

Values are mean ± SD or percent; n = 802. *Different from participants with CC genotype for APOA5 S19W, P < 0.05.

2

Expressed as the percent that each ancestral population contributes to total composition.

3

Three or more of the following conditions must be present: waist circumference ≥102 cm in men or ≥88 cm in women; fasting glucose ≥ 5.6 mmol/L; elevated blood pressure (SBP ≥ 130 or DBP ≥ 85 mm Hg); high TG (≥1.7 mmol/L); low HDL-C (<1.0 mmol/L in men or <1.3 mmol/L in women).